Plain-English translation of NCT07313384 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The DINE-GLP1 study wants to understand how people eating and nutrition needs change when they start , a medication that reduces appetite and helps with weight loss. Researchers know the medication works, but they don't know much about what patients actually experience eating less food, or what kind of nutrition guidance would help them stay healthy long-term. This study listens to patients' real-world experiences to help doctors give better support.
As more people use this medication, there's a gap in nutrition guidance—doctors focus mainly on managing side effects and reducing calories, but not on helping patients eat nutritiously while eating less. Understanding what patients need will help create better, lasting solutions for successful weight management.
You would complete short surveys and food tracking records using your smartphone or computer as you start and continue the medication. The study follows your eating habits and nutrition experiences over time to learn what support would help you most. This is an observational study—researchers are listening and learning from your experience, not testing a new medication.
AI-generated summary from trial data · Aug 13, 2026 · Not medical advice
United States